Jacqualyn A. Fouse, Director at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 21,436 shares at $28.36 ($608K) on 2023-06-30, disclosed to the SEC on 2023-06-30.
Scheduled sale ($608k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.36 | 10,718 | $304K | 50.0% |
| 2 | $28.36 | 10,718 | $304K | 50.0% |
| Total | $28.36 avg | 21,436 | $608K | 100% |
| Filing → |
| AGIO | SELL | 2024-01-24 | $464K | — | Filing → |
| AGIO | SELL | 2024-01-09 | $386K | — | Filing → |
| AGIO | BUY | 2019-11-15 | $1.2M | — | Filing → |